the invention relates to particular substituted heterocycle fused gamma - carbolines , their prodrugs , in free , pharmaceutically acceptable salt and / or substantially pure form as described herein , pharmaceutical compositions thereof , and methods of use in the treatment of diseases involving 5 - ht 2a receptor , serotonin transporter and / or pathways involving dopamine d 2 receptor signaling systems .